Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 2
2014 1
2017 3
2018 8
2019 2
2020 2
2021 3
2022 1
2023 2
2024 3
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

24 results

Results by year

Filters applied: . Clear all
Page 1
Enfortumab Vedotin and Pembrolizumab in Untreated Advanced Urothelial Cancer.
Powles T, Valderrama BP, Gupta S, Bedke J, Kikuchi E, Hoffman-Censits J, Iyer G, Vulsteke C, Park SH, Shin SJ, Castellano D, Fornarini G, Li JR, Gümüş M, Mar N, Loriot Y, Fléchon A, Duran I, Drakaki A, Narayanan S, Yu X, Gorla S, Homet Moreno B, van der Heijden MS; EV-302 Trial Investigators. Powles T, et al. N Engl J Med. 2024 Mar 7;390(10):875-888. doi: 10.1056/NEJMoa2312117. N Engl J Med. 2024. PMID: 38446675 Clinical Trial.
Association of PD-1, LAG-3 and TIM-3 expression on intratumoral CD8 T-cells with response to atezolizumab in a Real-World-Evidence biomarker study for advanced urothelial carcinoma patients.
de Andrea CE, Abengozar-Muela M, Arranz JÁ, Climent MA, Puente J, Vizcay Á, Montero de la Fuente L, Jurado JM, Bonfill T, Santander C, Villa JC, Pujol E, Rosero AC, Gomez J, Fernández EM, Álvarez Fernández C, Ramirez I, Arnáiz P, López-Janeiro Á, Melero I, Sanmamed MF, Pérez-Gracia JL. de Andrea CE, et al. Among authors: bonfill t. Oncoimmunology. 2025 Dec;14(1):2538687. doi: 10.1080/2162402X.2025.2538687. Epub 2025 Aug 8. Oncoimmunology. 2025. PMID: 40778981 Free article.
Durvalumab in combination with BCG for BCG-naive, high-risk, non-muscle-invasive bladder cancer (POTOMAC): final analysis of a randomised, open-label, phase 3 trial.
De Santis M, Palou Redorta J, Nishiyama H, Krawczyński M, Seyitkuliev A, Novikov A, Guerrero-Ramos F, Zukov R, Kato M, Kawahara T, Goeman L, Puente J, Hellmis E, Powles T, Radziszewski P, Gust KM, Vasey P, Bigot P, Fradet Y, Hunting J, Armstrong J, Boulos S, Hois S, Shore ND; POTOMAC Investigators. De Santis M, et al. Lancet. 2025 Nov 8;406(10516):2221-2234. doi: 10.1016/S0140-6736(25)01897-5. Epub 2025 Oct 17. Lancet. 2025. PMID: 41115436 Clinical Trial.
The role of immunotherapy in non-clear cell renal cell carcinoma.
Climent C, Soriano S, Bonfill T, Lopez N, Rodriguez M, Sierra M, Andreu P, Fragio M, Busquets M, Carrasco A, Cano O, Seguí MA, Gallardo E. Climent C, et al. Among authors: bonfill t. Front Oncol. 2023 Feb 3;13:941835. doi: 10.3389/fonc.2023.941835. eCollection 2023. Front Oncol. 2023. PMID: 36816976 Free PMC article. Review.
Induction avelumab followed by chemoimmunotherapy and maintenance versus chemotherapy alone as first-line therapy in cis-ineligible metastatic urothelial carcinoma (INDUCOMAIN): a randomized phase II study.
Rodriguez-Vida A, Valderrama BP, Castellano D, Pinto A, Mellado B, Puente J, Climent MA, Domenech M, Vazquez F, Perez-Gracia JL, Bonfill T, Morales-Barrera R, Gonzalez-Billalabeitia E, Garcia-Del-Muro X, Maroto P, Navarro-Gorro N, Juanpere N, Juan O, Bellmunt J. Rodriguez-Vida A, et al. Among authors: bonfill t. ESMO Open. 2024 Sep;9(9):103690. doi: 10.1016/j.esmoop.2024.103690. Epub 2024 Aug 29. ESMO Open. 2024. PMID: 39214051 Free PMC article. Clinical Trial.
Dual mTOR1/2 Inhibitor Sapanisertib (FTH-003/TAK-228) in Combination With Weekly Paclitaxel in Patients With Previously Treated Metastatic Urothelial Carcinoma: A Phase II Open-Label Study.
Bellmunt J, Maroto P, Bonfill T, Vazquez F, Perez-Gracia JL, Juanpere N, Hernandez-Prat A, Hernandez-Llodra S, Rovira A, Juan O, Rodriguez-Vida A. Bellmunt J, et al. Among authors: bonfill t. Clin Genitourin Cancer. 2024 Oct;22(5):102123. doi: 10.1016/j.clgc.2024.102123. Epub 2024 May 23. Clin Genitourin Cancer. 2024. PMID: 38905731 Clinical Trial.
SEOM clinical guideline in nasopharynx cancer (2017).
Pastor M, Lopez Pousa A, Del Barco E, Perez Segura P, Astorga BG, Castelo B, Bonfill T, Martinez Trufero J, Grau JJ, Mesia R. Pastor M, et al. Among authors: bonfill t. Clin Transl Oncol. 2018 Jan;20(1):84-88. doi: 10.1007/s12094-017-1777-0. Epub 2017 Nov 2. Clin Transl Oncol. 2018. PMID: 29098554 Free PMC article.
Epidemiology of human papillomavirus-related oropharyngeal cancer in a classically low-burden region of southern Europe.
Mena M, Frias-Gomez J, Taberna M, Quirós B, Marquez S, Clavero O, Baena A, Lloveras B, Alejo M, León X, García J, Mesía R, Bermejo O, Bonfill T, Aguila A, Guix M, Hijano R, Pavón MA, Torres M, Tous S, Clèries R, Alemany L. Mena M, et al. Among authors: bonfill t. Sci Rep. 2020 Aug 6;10(1):13219. doi: 10.1038/s41598-020-70118-7. Sci Rep. 2020. PMID: 32764593 Free PMC article.
Prevalence of immune-related adverse events and anti-tumor efficacy in advanced/metastatic urothelial carcinoma following immune-checkpoint inhibitor treatment.
Morales-Barrera R, Villacampa G, Vidal N, Figols M, Giner J, Bonfill T, Suárez C, Díaz N, Mateo J, González M, Domenech M, Puente J, Carles J. Morales-Barrera R, et al. Among authors: bonfill t. Clin Transl Oncol. 2023 Dec;25(12):3556-3564. doi: 10.1007/s12094-023-03213-6. Epub 2023 May 22. Clin Transl Oncol. 2023. PMID: 37217634
Radium-223 for patients with metastatic castration-resistant prostate cancer with asymptomatic bone metastases progressing on first-line abiraterone acetate or enzalutamide: A single-arm phase II trial.
Carles J, Alonso-Gordoa T, Mellado B, Méndez-Vidal MJ, Vázquez S, González-Del-Alba A, Piulats JM, Borrega P, Gallardo E, Morales-Barrera R, Paredes P, Reig O, Garcías de España C, Collado R, Bonfill T, Suárez C, Sampayo-Cordero M, Malfettone A, Garde J. Carles J, et al. Among authors: bonfill t. Eur J Cancer. 2022 Sep;173:317-326. doi: 10.1016/j.ejca.2022.06.057. Epub 2022 Aug 16. Eur J Cancer. 2022. PMID: 35981452 Free article. Clinical Trial.
24 results